Longevity Medicine

Rapidly restores micronutrient deficiencies and supports energy, immune function, skin quality and cognitive clarity — especially valuable after lab-confirmed deficits or demanding periods.

Administered intravenously, individually dosed based on lab work. No fasting or preparation required.

45–60 minutes per session. Typically 2–4 sessions per month depending on the protocol.

Well tolerated, medically supervised. Individual contraindications are checked at the initial consultation.

Supports cellular energy production, regulates aging pathways and noticeably affects fatigue, sleep quality and cognitive sharpness — particularly relevant during high regeneration phases.

Slow intravenous infusion, individually titrated dose (250–1000 mg). Tolerance is closely monitored throughout administration.

1–3 hours per session. Initial phase: 4–6 sessions in 2–4 weeks, then a maintenance rhythm every 4–8 weeks.

Absolute contraindications: active malignancy in certain stages, pregnancy and breastfeeding.

Supports protein synthesis, wound healing and recovery after intense training, surgery or in catabolic phases. Relevant for insufficient oral intake, sarcopenia prevention and performance optimisation.

Personalised formula based on amino-acid lab profile. Administered intravenously, frequently combined with vitamin or NAD+ infusions.

45–60 minutes per session. Typically 2–4 sessions per month depending on goal and training cycle.

Well tolerated, medically supervised. Kidney function is checked at the initial consultation.

Activates cytochrome-c-oxidase in the mitochondria, improves microcirculation and modulates inflammatory processes. Often combined with infusion protocols.

Administered through a venous access, frequently in parallel with a vitamin or NAD+ infusion.

30 minutes per session. Typical series: 6–10 sessions over 3–6 weeks.

Gentle, no downtime. Best combined with systemic infusions.

Stimulates the body's antioxidant systems, acts immunomodulatory and supports low-grade chronic inflammation.

Closed system — blood is treated with ozone outside the body and returned. Strictly performed by a physician.

45–60 minutes per session. Typical protocol: 4–8 sessions over 4–8 weeks.

Only performed in certified practices. Contraindications are excluded at the initial consultation.

Mesenchymal stem cells release growth factors and immunomodulatory signals — applied in joint concerns, tissue regeneration and chronic recovery phases.

Local or systemic application after clinical review and current lab status. Only certified preparations with traceable origin.

60–90 minutes per application. Protocol is individual — typically 1–3 sessions over several weeks.

Indications are strictly reviewed. Contraindications during active oncological therapy and pregnancy.

Exosomes transport miRNA, proteins and growth factors between cells and initiate repair processes — without transferring foreign cells.

Administered intravenously or locally depending on indication. Only GMP-certified preparations with documented origin and release testing.

45–60 minutes per session. Typically 1–4 applications per protocol.

Only with verifiable certificates. Contraindications are clinically reviewed before every application.

Depending on the peptide: regenerative, immunomodulatory or metabolic effects. Consulting covers indication review, dosing strategy and monitoring based on lab values.

In-depth consultation, indication review and protocol planning. Administration is usually subcutaneous, occasionally oral or sublingual — after clear medical clearance.

60-minute initial consultation. Protocol cycles typically 4–12 weeks, accompanied by lab monitoring.

Only approved or regulatory-accepted peptides. Contraindications during active oncological therapy or pregnancy.

Combines extended lab diagnostics with nutrition, movement and micronutrient strategies. Supportive in fatigue, metabolic disorders and hormonal imbalances.

In-depth medical history, individual diagnostics and an integrated treatment plan over 3–12 months — with clear checkpoints.

60–90 minute initial consultation. Follow-ups every 4–12 weeks depending on goal.

Complements conventional diagnostics and therapy — not a replacement. Works interdisciplinarily with your specialists.

Genetic tests highlight relevant predispositions (cardiovascular, metabolic, neurodegenerative, pharmacogenetic). Epigenetic analyses measure biological age via DNA methylation patterns and allow progress tracking under therapy.

Single blood or saliva sample, processed in a certified specialty lab via the Dripfy infrastructure. Findings are interpreted in a dedicated consultation and translated into the overall protocol.

Sampling 10 minutes. Report in 2–4 weeks. Genetic diagnostics once; epigenetic progress measurement recommended every 12–24 months.

GDPR-compliant processing. Results are never shared without your explicit consent and remain in your hands.

NMR spectroscopy measures lipoprotein subfractions, amino acids, ketone bodies, inflammation markers and many metabolic parameters in parallel — providing a metabolic overview that classical panels miss, and especially valuable for precise protocol tuning.

Single fasting morning blood draw. The sample is analyzed through Dripfy partner labs. Results are discussed in a dedicated review consultation and translated into concrete therapy steps.

Blood draw 10 minutes. Results in 1–2 weeks. Typical control frequency: every 6–12 months within the protocol.

NMR metabolomics complements classical blood work — it does not replace it. Both layers are interpreted together.

Supports metabolism, inflammation balance, gut health and long-term cardiometabolic health.

In-depth initial consultation, lab review, individual plan with food recommendations and supplement protocol.

60-minute initial session, 30-minute follow-ups every 3–6 months.

Complementary to medical recommendations — not a replacement but a deeper layer.